Unusual association of multiple sclerosis and tomaculous neuropathy

Journal of the Neurological Sciences

Volumn 157, Issue 2, 1998, Pages 217-222

  Drulović, Jelena ^a   Dožić, Slobodan ^a   Lević, Zvonimir ^a   Stojsavljević, Nebojša ^a   Trikić, Rajko ^a   Cvetković, Dubravka ^a   Apostolski, Slobodan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anti GM1 antibody; Monoclonal gammopathy of undetermined significance; Multiple sclerosis; Polyneuropathy; Sural nerve biopsy; Tomaculous neuropathy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DEMYELINATION; FEMALE; HUMAN; MULTIPLE SCLEROSIS; NERVE BIOPSY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SURAL NERVE;

EID: 0032493108     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00054-9     Document Type: Article

References (37)

1. Acarin N., Rio J., Fernandez A.L., Tintore M., Duran I., Galan I., Montalban X. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol. Scand. 93:1996;99-103.
2. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genet. 11:1995;274-280.
3. Amato A.A., Barohn R.J. Hereditary neuropathy with liability to pressure palsies: association with central nervous system demyelination. Muscle Nerve. 19:1996;770-773.
4. Amato A.A., Gronseth G.S., Callerame K.J., Kaga-Hallet K.S., Brayan W.W., Barohn R.J. Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5 Mb deletion in chromosome 17p11.2. Muscle Nerve. 19:1996;16-22.
5. Apostolski S., Latov N. Clinical syndromes associated with anti-GM1 antibodies. Semin. Neurol. 13:1993;264-268.
6. Bradley W.G., Madrid R., Thrush D.C., Campbell M.J. Recurrent brachial plexus neuropathy. Brain. 98:1975;381-398.
7. Chance P., Alderson M.K., Leppig K.A., Lensch M.W., Matsunami N., Smith B., Swanson P.D., Odelberg S.J., Disteche C.M., Bird T.D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 72:1993;143-151.
8. Endo T., Scott D.D., Scott Stewart S., Kundu S.K., Marcus D.M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J. Immunol. 132:1984;1793-1797.
9. Fazekas F., Offenbacher H., Fuchs S., Schmidt R., Niederkorn K., Horner S., Lechner H. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 38:1988;1822-1825.
10. Forrester C., Lascelles R.G. Association between polyneuritis and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 42:1979;864-866.
11. Joy J.L., Oh S.J. Tomaculous neuropathy presenting as acute recurrent polyneuropathy. Ann. Neurol. 26:1989;98-100.
12. Lassmann H., Budka H., Schnaberth G. Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch. Neurol. 38:1981;99-102.
13. Malandrini A., Guazzi G.C., Federico A. Sensory-motor polyneuropathy in two siblings: atypical presentation of tomaculous neuropathy. Clin. Neuropathol. 11:1992;318-322.
14. Madrid R., Bradley W.G. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy). Studies on the formation of the abnormal myelin sheath. J. Neurol. Sci. 25:1975;415-448.
15. Nardelli E, Pizzighella S, Tridente G, Rizzuro N. Peripheral neuropathy associated with immunoglobulin disorders: an immunological and ultrastructural study. Acta Neuropathol 1981;Suppl 8:258-261.
16. Ohnishi A. Pathologic aspects of inherited neuropathies in relation to genetic abnormalities (abstract). Muscle Nerve 1994; Suppl 1:S64.
17. Ormerod I.E., Waddy H.M., Kermode A.G., Murray N.M., Thomas P.K. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J. Neurol. Neurosurg. Psychiatry. 53:1990;789-793.
18. Osby L.E., Noring L., Hast R., Kjellin K.G., Knutsson E., Siden A. Benign monoclonal gammopathy and peripheral neuropathy. Br. J. Haematol. 51:1982;531-539.
19. Pollock M., Calder C., Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann. Neurol. 2:1977;41-48.
20. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F., Ebers G.C., Johnson H., Sibley W., Silberberg D., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocol. Ann. Neurol. 13:1983;227-231.
21. Ro Y.I., Alexander C.B., Oh S.J. Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy. Muscle Nerve. 6:1983;312-316.
22. Rosenberg N.L., Bourdette D. Hypertrophic neuropathy and multiple sclerosis. Neurology (Cleveland). 33:1983;1361-1364.
23. Rubin M., Karpati G., Carpenter S. Combined central and peripheral myelinopathy. Neurology. 37:1987;1287-1290.
24. Sanders E.A., Lee K.D. Acute Guillain-Barré syndrome in multiple sclerosis. J. Neurol. 234:1987;128.
25. Sarova-Pinhas I., Achiron A., Gilad R., Lampl Y. Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Acta Neurol. Scand. 91:1995;234-238.
26. Sadiq S.A., Thomas F.P., Kilidireas K., Protopsaltis S., Hays A.P., Lee K-W.et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 40:1990;1067-1072.
27. Schoene W.C., Carpenter W.C., Behan P.O., Geschwind N. 'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain. 100:1977;755-773.
28. Shefner J.M., Carter J.L., Krarup C. Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve. 15:1992;73-76.
29. Smith I.S., Kahn S.N., Lacey B.W., King R.H., Eames R.A., Whybrew D.J., Thomas P.K. Chronic demyelinating neuropathy associated with benign IgM paraproteinemia. Brain. 106:1983;169-195.
30. Stevens A., Weller M., Wietholter H. CSF and serum ganglioside antibody patterns in MS. Acta Neurol. Scand. 86:1992;485-489.
31. Thomas P.K., Walker R.W.H., Rudge P., Morgan-Hughes J.A., King R.H.M., Jacobs J.M., Mills K.R., Ormerod I.E.C., Murray N.M.F., McDonald W.I. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 110:1987;53-76.
32. Trefouret S., Azulay J-Ph., Pouget J., Boucraut J., Serratrice G. Sclerose en plaques tardive et gammapathie monoclonale serique: association fortuite? Rev. Neurol. (Paris). 152:1996;554-556.
33. Tsung S.H. Monoclonal gammopathy associated with multiple sclerosis. Ann. Clin. Lab. Sci. 8:1978;472-475.
34. Uncini A., Di Guiglielmo G., Di Muzio A., Gambi D., Sabatelli M., Mignogna T., Tonali P., Marzella R., Finelli P., Archidiacono N., Rocchi M. Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication. Muscle Nerve. 18:1995;628-635.
35. Verhalle D., Lofgren A., Nelis E., Dehaene I., Theys P., Lammens M., Dom R., Van Broeckhoven C., Robberecht W. Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann. Neurol. 35:1994;704-708.
36. Vital C., Pautrizel B., Lagueny A., Vital A., Bergouignan F.X., David B., Loiseau P. Hypermyelinisation dans un cas de neuropathie peripherique avec gammapathie monoclonale benigne a IgM. Rev. Neurol. (Paris). 141:1985;729-734.
37. Windebank AJ. Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy (3rd ed). Philadelphia: WB Saunders, 1993:1137-1148.